Clinical trial
Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients
NCT00308945 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00308945 |
|---|---|
| Title | Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients |
| Official title | Influence of Travoprost 0.004% and Latanoprost 0.005% on Retinal Vascular Diameter and Choroidal Blood Flow in Glaucoma Patients |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Open-Angle Glaucoma |
| Intervention type | Drug |
| Interventions | travoprost 0.004% (drug), latanoprost 0.005% (drug) |
| Enrollment | 20 |
| Start date | Nov 1, 2003 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Mar 30, 2006 |
| Last update posted | Jan 17, 2008 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: